Stock Events

Stock Events

Galectin Therapeutics (GALT) Q3 2025 Earnings

14AugConfirmed

Q3 2024

Q4 2024

Q2 2025

Q3 2025

-0.2

-0.17

-0.15

-0.12

Details

Expected EPS

-0.16

Actual EPS

-0.12

Surprise EPS

0.04

Surprise Percent

+25%

Description

Galectin Therapeutics (GALT) has reported earnings of -0.12 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.